See also this year's filing and all EDGAR filings for this company.
PDF Report 0001875558_2023_Nuvectis_Pharma_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001875558', 'EntityCommonStockSharesOutstanding': 14752403, 'Assets': 20405000, 'AssetsCurrent': 20405000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 6186000, 'LiabilitiesAndStockholdersEquity': 20405000, 'LiabilitiesCurrent': 6186000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -19085000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 149000, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 14219000, 'remainder_NetIncome': -19234000, 'remainder_Revenues': 149000, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001875558')"} |
Edgar->Model Mapping
